Found 24 matching trials
A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis
N/AImmunothrombosis has recently been used to describe the responses/mechanism...
Location
the Affiliated Hospital of Qingdao University
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NAOvarian cancer (OC) is one of the most lethal cancers in the world due to l...
Location
Catharina Hospital
9 Minutes for Tandem Colonoscopy Withdrawal
NAA mean withdrawal time of at least 6 minutes has been considered to be one ...
Location
Changhai Hospital, Second Military Medical University
Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
N/AThe purpose of this retrospective study was to investigate the diagnostic p...
Location
West China Hospital of Sichuan Univerisity
Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients
NARationale In a very short time corona virus disease 2019 (COVID-19) has bec...
Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD
N/AA observational diagnostic study will be conducted to evaluate the performa...
Location
The Fifth Affiliated Hospital, Sun Yat-sen University
Two-dimensional Shear Wave Elastography for Assessment of Cirrhosis and Portal Hypertension
N/AExploring and establishing new non-invasive risk stratification techniques ...
Location
Multiple Locations
Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular Disorder
NAPorto-sinusoidal vascular disorder (PSVD) is considered a rare cause of por...
Location
Hospital Universitário Clementino Fraga Filho / Universidade Federal do Rio de Janeiro (UFRJ)
Cardiac Dysfunction in Patients with Fatty Liver Disease
N/ACirrhotic cardiomyopathy is seen as a blunted contractile responsiveness to...
Location
Dr. Madhumita Premkumar
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects
PHASE1This study is designed to examine safety, tolerability, pharmacokinetics, p...
Location
GSK Investigational Site